Powell, Timothy R <br/><br/>
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response.  [electronic resource] 

 -  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology  Sep 2013 
 - 1105-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7862 
<br/><br/><label>Standard No.: </label>10.1016/j.euroneuro.2012.09.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers--metabolism<br/>Citalopram--administration & dosage<br/>Cytokines--biosynthesis<br/>Depressive Disorder--drug therapy<br/>Drug Delivery Systems--methods<br/>Female<br/>Humans<br/>Inflammation Mediators--metabolism<br/>Male<br/>Middle Aged<br/>Pharmacogenetics--methods<br/>Polymorphism, Single Nucleotide--genetics<br/>Selective Serotonin Reuptake Inhibitors--administration & dosage<br/>Transcriptome--physiology<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--biosynthesis<br/>Young Adult